Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06625775
Title Dose Escalation and Expansion of BBO-10203 in Advanced Solid Tumors (BREAKER-101)
Acronym BREAKER-101
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors TheRas, Inc., d/b/a BridgeBio Oncology Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST